International Society for Heart and Lung Transplantation

Jon Kobashigawa MD

Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, United States

Appearances

CONCURRENT SESSION 38: Cloudy with a Chance of T-Cells: Rejection Forecast -- The Time Course of Development of Anti-Human Leukocyte Antigen Antibodies Crucial for Monitoring and Potential Intervention Following Heart Transplantation
Core Competencies in Heart Failure and Transplant Medicine
Approach to the Highly Sensitized Patient Awaiting Heart Transplantation
The Tempest (Controlling the Immune System in Heart Transplantation)
PRE-MEETING SYMPOSIUM 23: A 2016 Focused Update on AMR in Cardiac Transplantation: Immunologic Diagnostics and the Treatment of Refractory AMR -- Management of Antibodies in Heart Transplantation: Insights from 2016 Consensus Conference
CONCURRENT SESSION 11: The Heartbreak of Rejection: All Against the Graft -- Initial Analysis of the Donor-Derived Cell-Free DNA - Outcomes AlloMap Registry (D-OAR) Study in Heart Transplant Recipients Undergoing Surveillance for Rejection
SYMPOSIUM 3: Primary Graft Dysfunction (PGD) and Vasoplegia After Heart Transplantation: Sink or Swim
ORAL SESSION 36 - Antibodies and Rejection in Heart Transplantation: Donor Cells Tell No Lies
ORAL SESSION 47 - A Melange of Outcomes in Heart Transplantation
RESEARCH SESSION 16: Junior Faculty and Trainees Clinical Case Dilemmas: The Best of the Best
RESEARCH SESSION 39: Walking a Tightrope: The Double-Edged Sword of Drugs after Heart Transplant
RESEARCH SESSION 45: Acute Cardiac Rejection: New Approaches to an Old Problem
RESEARCH SESSION 80: Heart Transplant Long-Term Outcomes: In It for the Long Haul
RESEARCH SESSION 24: Molecular Diagnostics in Heart Transplantation: It's All in the Genes

Item	Price	Remove